Unknown

Dataset Information

0

Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer.


ABSTRACT: Cobicistat (3, GS-9350) is a newly discovered, potent, and selective inhibitor of human cytochrome P450 3A (CYP3A) enzymes. In contrast to ritonavir, 3 is devoid of anti-HIV activity and is thus more suitable for use in boosting anti-HIV drugs without risking selection of potential drug-resistant HIV variants. Compound 3 shows reduced liability for drug interactions and may have potential improvements in tolerability over ritonavir. In addition, 3 has high aqueous solubility and can be readily coformulated with other agents.

SUBMITTER: Xu L 

PROVIDER: S-EPMC4007915 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6710528 | biostudies-literature
| S-EPMC3306292 | biostudies-literature
| S-EPMC7668297 | biostudies-literature
| S-EPMC2575030 | biostudies-literature
| S-EPMC4778748 | biostudies-literature
| S-EPMC5118987 | biostudies-literature
| S-EPMC2650545 | biostudies-literature
| S-EPMC5066159 | biostudies-literature
| S-EPMC4798913 | biostudies-literature
| S-EPMC5399127 | biostudies-literature